A study published in the Journal of Medical Toxicology by researchers at the University of Alabama at Birmingham found that ...

A team of researchers at Rowan University has developed an injectable biomaterial that could significantly improve recovery ...

Elite Pharmaceuticals, Inc., a specialty pharmaceutical company engaged in the development, manufacture, and distribution of niche generic products, today reported positive results from a pivotal ...

Once commenced, the bioequivalence study is relatively short, scheduled for less than 30 days from start to finish.

Once commenced, the bioequivalence study is relatively short, scheduled for less than 30 days from start to finish. The Company plans to make further updates in the coming weeks regarding its ...

Eton Pharmaceuticals reports successful bioequivalence of ET-600 and plans NDA submission in April 2025 for diabetes insipidus treatment.

New Delhi: Accepting the bioequivalence study report for Type 2 Diabetes Mellitus, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has ...

Subsequently, the developed methodology was applied in a bioequivalence study involving anemia patients. The in-study quality control results demonstrated that the method was highly accurate, with ...

Kashiv Biosciences has reported that a trial of its 125mg/mL pre-filled syringe injection, KSHB002, has achieved its primary endpoints.

Sam Chun Dang Pharm said Wednesday that it has initiated a bioequivalence study for its oral semaglutide, a generic version of Novo Nordisk’s Rybelsus tablets. The product is developed using the ...

Syngene has embarked on evaluating bioequivalence of an injectable for type-2 diabetes and weight management. This was after a global pharma company was scouting for a partner to outsource its human ...

Syngene has embarked on evaluating bioequivalence of an injectable for type-2 diabetes and weight management. This was after a global pharma company was scouting for a partner to outsource its human ...